TFF3 and prostate carcinoma: As we know TFF3 is a soluble peptide containing trefoil domain and C-terminal dimerization domain which is not only a novel prognostic marker but also a therapeutic target in various cancers, such as mammary carcinoma, gastric cancer and prostate carcinoma [5–8].